[go: up one dir, main page]

IL166539A - Method for diagnosing multiple sclerosis - Google Patents

Method for diagnosing multiple sclerosis

Info

Publication number
IL166539A
IL166539A IL166539A IL16653905A IL166539A IL 166539 A IL166539 A IL 166539A IL 166539 A IL166539 A IL 166539A IL 16653905 A IL16653905 A IL 16653905A IL 166539 A IL166539 A IL 166539A
Authority
IL
Israel
Prior art keywords
multiple sclerosis
diagnosing multiple
diagnosing
glycans
antibodies
Prior art date
Application number
IL166539A
Other versions
IL166539A0 (en
Original Assignee
Glycominds Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycominds Ltd filed Critical Glycominds Ltd
Publication of IL166539A0 publication Critical patent/IL166539A0/en
Publication of IL166539A publication Critical patent/IL166539A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Testing Of Engines (AREA)
  • Heat Treatment Of Steel (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Control Of Electric Motors In General (AREA)

Abstract

Disclosed is a method for diagnosing multiple sclerosis and more particularly to a method for diagnosing multiple sclerosis by measuring levels of antibodies to glycans in a biological sample.
IL166539A 2002-08-02 2005-01-27 Method for diagnosing multiple sclerosis IL166539A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40091402P 2002-08-02 2002-08-02
US44707603P 2003-02-13 2003-02-13
US46298403P 2003-04-15 2003-04-15
US47323103P 2003-05-23 2003-05-23
PCT/IB2003/003878 WO2004015420A1 (en) 2002-08-02 2003-08-04 Method for diagnosing multiple sclerosis

Publications (2)

Publication Number Publication Date
IL166539A0 IL166539A0 (en) 2006-01-15
IL166539A true IL166539A (en) 2010-11-30

Family

ID=31721743

Family Applications (1)

Application Number Title Priority Date Filing Date
IL166539A IL166539A (en) 2002-08-02 2005-01-27 Method for diagnosing multiple sclerosis

Country Status (18)

Country Link
US (2) US7537900B2 (en)
EP (1) EP1529216B1 (en)
JP (2) JP4721703B2 (en)
AT (1) ATE376672T1 (en)
AU (1) AU2003263409B2 (en)
BR (1) BR0313194A (en)
CA (1) CA2494422A1 (en)
CY (1) CY1107859T1 (en)
DE (1) DE60317070T2 (en)
DK (1) DK1529216T3 (en)
ES (1) ES2297248T3 (en)
IL (1) IL166539A (en)
MX (1) MXPA05001270A (en)
NO (1) NO20051024L (en)
NZ (1) NZ585114A (en)
PL (1) PL210512B1 (en)
PT (1) PT1529216E (en)
WO (1) WO2004015420A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003263409B2 (en) * 2002-08-02 2010-05-27 Glycominds Ltd. Method for diagnosing multiple sclerosis
US7592150B2 (en) 2003-12-03 2009-09-22 Glycominds, Ltd Method for diagnosing diseases based on levels of anti-glycan antibodies
AU2004294526A1 (en) 2003-12-03 2005-06-16 Glycominds, Ltd Method for diagnosing diseases based on levels of anti-glycan antibodies
WO2006002382A2 (en) * 2004-06-24 2006-01-05 The Scripps Research Institute Arrays with cleavable linkers
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis
US8216791B2 (en) 2005-01-31 2012-07-10 Glycominds Ltd. Method for diagnosing multiple sclerosis
EP2517727A3 (en) * 2005-09-29 2013-10-30 Caprion Proteomics USA, LLC Biomarkers for multiple sclerosis and methods of use thereof
US20100203569A1 (en) * 2009-02-12 2010-08-12 Glycominks LTD Method for Evaluating Risk in Multiple Sclerosis
US20120190581A1 (en) * 2009-08-25 2012-07-26 The Johns Hopkins University Detection of Auto-Antibodies to Specific Glycans as Diagnostic Tests for Autoimmune Diseases
CA2940579A1 (en) 2014-03-13 2015-09-17 Universitaet Basel Carbohydrate ligands that bind to igm antibodies against myelin-associated glycoprotein
WO2016026143A1 (en) * 2014-08-22 2016-02-25 Huiru Wang Saccharide-based biomarkers and therapeutics
US10495646B2 (en) 2015-01-30 2019-12-03 The Regents Of The University Of California N-acetyl glucosamine as a biomarker of MS disease course
AU2016323377B2 (en) 2015-09-16 2021-04-15 Universität Basel Carbohydrate ligands that bind to antibodies against glycoepitopes of glycosphingolipids
CN115684612A (en) * 2016-07-01 2023-02-03 尊严健康公司 Diagnostic or prognostic factor for relapsing-remitting form of multiple sclerosis
EP3775911A1 (en) * 2018-04-03 2021-02-17 Creatics LLC Methods for cancer detection by evaluation of glycan-binding patterns of immunoglobulins in gastrointestinal lavage fluid samples

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US5030560A (en) * 1988-11-04 1991-07-09 Immucor, Inc. Method for drying mammalian cells for use in solid phase immunoassays and articles incorporating same
JPH02161357A (en) * 1988-12-15 1990-06-21 Tosoh Corp Method for stabilizing material for immunosassay
US20010051349A1 (en) * 2000-02-17 2001-12-13 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
MXPA01008236A (en) 1999-02-17 2003-07-21 Glycominds Ltd Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof.
US6762032B1 (en) * 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
EP1248678A1 (en) * 2000-01-10 2002-10-16 Genospectra, Inc. Linear probe carrier
AU2001288431A1 (en) * 2000-08-28 2002-03-13 The Trustees Of Columbia University In The City Of New York Detection of anti-glycolipid antibodies by latex agglutination assay
ITFI20010114A1 (en) 2001-06-22 2002-12-22 Univ Firenze GLYCOPEPTIDES, THEIR PREPARATION AND THEIR USE IN THE DIAGNOSIS OR THERAPEUTIC TREATMENT OF MULTIPLE SCLEROSIS
US20040241763A1 (en) * 2002-08-02 2004-12-02 Nir Dotan Method for diagnosing multiple sclerosis
AU2003263409B2 (en) * 2002-08-02 2010-05-27 Glycominds Ltd. Method for diagnosing multiple sclerosis
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis

Also Published As

Publication number Publication date
ES2297248T3 (en) 2008-05-01
JP4721703B2 (en) 2011-07-13
EP1529216B1 (en) 2007-10-24
DE60317070D1 (en) 2007-12-06
PL210512B1 (en) 2012-01-31
AU2003263409A1 (en) 2004-02-25
PT1529216E (en) 2008-01-30
DK1529216T3 (en) 2008-02-25
IL166539A0 (en) 2006-01-15
US20100081160A1 (en) 2010-04-01
JP2009258138A (en) 2009-11-05
CA2494422A1 (en) 2004-02-19
BR0313194A (en) 2005-07-12
MXPA05001270A (en) 2005-08-03
US7537900B2 (en) 2009-05-26
PL374869A1 (en) 2005-11-14
WO2004015420A8 (en) 2004-09-10
WO2004015420A1 (en) 2004-02-19
ATE376672T1 (en) 2007-11-15
NO20051024L (en) 2005-05-02
WO2004015420B1 (en) 2004-04-29
EP1529216A1 (en) 2005-05-11
CY1107859T1 (en) 2013-06-19
DE60317070T2 (en) 2008-07-24
US20040077023A1 (en) 2004-04-22
JP2006501441A (en) 2006-01-12
AU2003263409B2 (en) 2010-05-27
NZ585114A (en) 2011-09-30

Similar Documents

Publication Publication Date Title
CY1107859T1 (en) METHOD FOR DIAGNOSTIC MULTIPLE SCIENCE
WO2006117689A3 (en) Method for diagnosing multiple sclerosis
AU2003298878A1 (en) Sample substrate for use in biological testing and method for filling a sample substrate
AU2002348289A8 (en) Method of using a non-antibody protein to detect and measure an analyte
GB2457856A (en) Cement bond analysis
EP1525534A4 (en) On-site analysis system with central processor and method of analysing
DE60228557D1 (en) CANDIDA-PROOF
AU2003278768A1 (en) Method and system for assessment of biomarkers by measurement of response to stimulus
EP1102988B8 (en) Method of determining the immune response activity of blood and test kit therefor
WO2003081236A3 (en) Method and device for predicting cardiovascular events
AU2001263771A1 (en) An assay method and kit for testing biological material for exposure to stress using biomarkers
AU2003257001A1 (en) A method of sample preparation for atom probes and source of specimens
AU2002233800A1 (en) Method and kit for predicting cancer
MXPA02009476A (en) Model transition sensitivity analysis system and method.
AU2003234787A1 (en) Instrument and method for measuring action signal of biological sample
DE602005024254D1 (en)
SE0002835D0 (en) Method and kit for production of monoclonal antibodies
IL171913A0 (en) Method of chromatographic analysis of a protein solution
GB0221216D0 (en) Method of measuring exhaust flow constituents
EP1636587A4 (en) Diagnostic kit for liver cirrhosis comprising an antibody specific for human protooncogenic protein
GB0317304D0 (en) An analysis apparatus arranged to analyse data and detect change and related methods
AU2002357820A8 (en) Diagnostic methods for protein profiling
RU94029889A (en) Caries progress prediction method
EP1801231A4 (en) SCREENING METHOD FOR A BAFF SUPPRESSOR OR INHIBITOR
UA11313U (en) Method for early prediction of infectious complications following total endoprosthetics of hip joint

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees